MYLIP Antibody

Size

100ul

Clone Number

Aliases

BM-023 antibody; BZF1 antibody; E3 ubiquitin protein ligase MYLIP antibody; E3 ubiquitin-protein ligase MYLIP antibody; Idol antibody; Inducible degrader of the LDL-receptor antibody; Lipoprotein receptor antibody; MIR antibody; MYLIP antibody; MYLIP_HUMAN antibody; Myosin regulatory light chain interacting protein antibody; PP5242 antibody

Immunogen Species

Homo sapiens (Human)

UniProt ID

Q8WY64

Immunogen

Recombinant Human E3 ubiquitin-protein ligase MYLIP protein (266-445AA)

Raised in

Rabbit

Species Reactivity

Human, Mouse

Tested Applications

ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

Background

E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.

Clonality

Polyclonal

Isotype

IgG

Purification Method

Antigen Affinity Purified

Conjugate

Non-conjugated

Buffer

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Form

Liquid

Stroage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names

MYLIP

Research Areas

Epigenetics and Nuclear Signaling; Cancer; Cardiovascular; Cell biology; Metabolism; Signal transduction